SSK 株式会社 新社会システム総合研究所

TOP調査レポートTOP > レポート詳細ページ

レポートカテゴリー

レポートのお問合せ

レポートについてのお問合せは

E-mail:nbd@ssk21.co.jp

まで、お気軽にご連絡ください。

調査会社一覧

No.R07C0001

2015年までのドラッグデリバリーデバイス市場展望(英語版)

The Drug Delivery Device Market Outlook to 2015

出版日 2011年1月
価格
Single User License(PDFタイプ) US$3835
Multi- User License(PDFタイプ) US$14381
ページ数 146ページ
発行<調査・編集> Business Insights
備考 ※お申込時の為替レートで換算致します。

申込フォームお問合せ

乱丁・落丁以外のご返品につきましては、原則としてお申し受けできませんのでご了承ください。

レポート内容

■概要■
 ドラッグデリバリーデバイスは、身体へ薬剤を投与するために使用される機械的な装置、または物理的なシステムと定義できる。本レポートは、ドラッグデリバリーデバイスのビジネスチャンス、市場環境、トレンド、新たな技術革新、そしてドラッグデリバリーシステムの主要なデバイスメーカについて、独自の見解を示している。

<特長とメリット>
・ドラッグデリバリーデバイス市場の市場規模および成長の可能性。

・ドラッグデリバリーデバイス市場における成長要因と阻害要因、トレンドを把握することによって、貴社のビジネス戦略に寄与すること。

・ドラッグデリバリーデバイス市場において、新たな技術革新や優位性を包括的に把握できること。

・ドラッグデリバリーデバイス市場の最も有望とされるセグメントを明確化することにより、意思決定のフレームワークを得られること。

・今後成長が見込まれる市場に効果的なビジネスを行う上で、主要なドラッグデリバリーデバイス企業のビジネス戦略を参考にすることができる。

<ハイライト>
 ドラッグデリバリーデバイス市場は、自己投与の増加傾向、患者や介護者の利便性、対象とされたドラッグデリバリー、安全性のメカニズムの必要性、生物薬剤の増加、慢性疾患の増加、ジェネリックとの差別化の必要性や競争からの保護の動きがあります。
 2009年においては、注射器タイプのドラッグデリバリーデバイスが最も大きなセグメントで、急速に成長したセグメントでもあります。しかしながら、市場は新規参入企業が増えたことにより、細分化されています。
 ドラッグデリバリーデバイスメーカは、購入権限がある大手製薬メーカ、そしてデバイス販売価格の低下によって、収益の幅が圧迫されている状況である。
 従来のシリンジやペンといったドラッグデリバリーデバイスは、急速に商品化が進み、利益率の減少につながっている。

-CONTENTS-
1.EXECUTIVE SUMMARY
・Introduction to the drug delivery device market
・Injectable drug delivery devices
・The inhalation drug delivery device market
・Transdermal drug delivery systems
・The implantable drug delivery device market

2.Introduction to the drug delivery device market
・Summary
・Introduction
・Drivers of the drug delivery device market
Patient and caregiver convenience
Increasing demand for targeted drug delivery
Need for safety mechanisms
Increasing market for biologics
Increase in the prevalence of chronic diseases
Need for differentiation
Protection from generic competition
・Resistors of the drug delivery device market
Low patient acceptance of some drug delivery systems
High failure and recall rates
Limitations of the molecules amenable to advanced drug delivery systems
・Global market outlook for drug delivery devices
・Market trends
Inhalation drug delivery devices
Implantable drug delivery devices
Injectable drug delivery devices
Transdermal products

3.Injectable drug delivery devices
・Summary
・Introduction
Advantages of parenteral drug delivery
Disadvantages of parenteral drug delivery
・Parenteral formulations market
・Market segmentation
Injectable devices
・Trends and innovations
Convenience and urgency
Safety
Self-administration
・Market outlook to 2015
Major players
Haselmeier
Owen Mumford
Bang & Olufsen Medicom
Safety Syringes
SHL Group
Rexam
Sanofi-aventis and Eli Lilly

4.The inhalation drug delivery device market
・Summary
・Introduction
Advantages of the pulmonary drug delivery route
Disadvantages of the pulmonary drug delivery route
Market size of inhalation formulations and inhalation devices
・Segmentation
Dry-powder inhaler (DPI)
Metered-dose inhaler (MDI)
Nebulizer
・Market outlook for inhalation drug delivery devices to 2015
・Innovations and advances
Dry-powder inhaler (DPI)
Metered-dose inhaler (MDI)
Nebulizers
・Major products and disease areas
Therapeutic classes of inhaled drugs
Disease areas
・Leading companies
3M Drug Delivery Systems
Valois Pharma
Nypro Healthcare
Aradigm

5.Transdermal drug delivery systems
・Summary
・Introduction
Types of TDDS
・Transdermal formulations market
Market segmentation by therapy area
Leading brands
・Trends and innovations
Penetration enhancers
Encapsulation
Iontophoresis
Cavitational ultrasound
Electroporation
Laser ablation/poration
Thermal ablation/poration
Radiofrequency thermal ablation
Microneedles
・Market outlook to 2015
・Major players
Novartis
J&J
Mylan
Watson
Boehringer Ingelheim

6.The implantable drug delivery device market
・Summary
・Introduction
Advantages of the implantable drug delivery route
Disadvantages of the implantable drug delivery route
Market size of implantable drug delivery devices
・Segmentation
Intrauterine devices
Implantable infusion pumps (IIP)
Drug implants
・Market outlook for implantable drug delivery devices to 2015
・Innovations and advances
Intrauterine devices
Drug implants
Implantable infusion pumps
・Major products and disease areas
Therapeutic classes and disease areas for implantable drugs
・Leading companies
Bayer Healthcare
Medasys
MicroCHIPS

Appendix
・Scope
・Methodology
・References
・Abbreviations

<図表>
Table: Global market outlook for drug delivery devices ($m), 2009-15
Table: Demand for traditional disposable syringes (million units), 2009
Table: Drugs and corresponding injection pen manufacturers
Table: Demand for multidose insulin cartridge by brand (million units), 2009
Table: Demand for multidose cartridge by company (million units), 2009
Table: Demand for reusable insulin pens (million units), 2008-09
Table: Demand for prefillable pens and syringes (million units), 2009
Table: Demand for prefillable syringes across therapy areas (million units), 2009
Table: Demand for prefillable syringes across leading brands (million units), 2009
Table: Demand for prefillable syringes across companies (million units), 2009
Table: Demand for prefillable pens across therapy areas (million units), 2009
Table: Demand for prefilled pens across leading brands (million units), 2009
Table: Demand for prefillable pens across companies (million units), 2009
Table: Safety syringe types
Table: Marketed products available in autoinjector platform
Table: Representative list of FDA-approved jet injectors
Table: Insulin pump market outlook, 2009-15
Table: Global market outlook for injectable devices, 2009-15
Table: Global market size of inhalation formulations ($bn), 2009
Table: Global market size of inhalation drug delivery devices ($m), 2009
Table: Examples of marketed dry-powder inhalers
Table: Outlook for inhalation drug delivery devices ($m), 2009-15
Table: Therapeutic classes of inhaled drugs
Table: Estimated prevalence of asthma across the seven major markets, 2009
Table: Estimated prevalence of COPD across the seven major markets, 2009
Table: Estimated prevalence of cystic fibrosis across the six major markets, 2009
Table: Leading TDDS therapy areas
Table: Leading TDDS brands
Table: Global market outlook for transdermal drug delivery devices, 2009-15
Table: Performance of leading TDDS manufacturers, 2008-09
Table: Global market size of implantable drug delivery devices
Table: Global market size of IUDs ($bn), 2009
Table: Global market size of implantable infusion pumps ($m), 2009
Table: Global market size of implantable formulations ($m), 2009
Table: Market outlook for implantable drug delivery devices ($m), 2009-15
Table: Therapeutic categories of implantable drugs
Table: Sales performance of Mirena ($m), 2007-09
Table: Sales performance of Implanon ($m), 2007-09
Table: Sales performance of Paragard ($m), 2007-09

Figure: Distribution of the global drug delivery device market by segment, 2015
Figure: Drug delivery device market size and growth by segment
Figure: Market segmentation of injectable formulations, 2009
Figure: Hypodermic syringe types
Figure: Typical injection pens
Figure: Multidose cartridge demand by insulin analog type (million units), 2009
Figure: Jet injection principle
Figure: Insulin pump
Figure: Global inhalation formulations market by type of device, 2009
Figure: Global inhalation drug delivery device market by type of device, 2009
Figure: Structure of a typical MDI
Figure: Distribution of the global MDI device market by type of propellant
Figure: Schematic diagram of a jet nebulizer
Figure: Schematic diagram of an ultrasonic nebulizer
Figure: Mechanism of Conix DPI
Figure: Components of the Respimat soft mist inhaler
Figure: Device market share for β2 stimulants + inhaled corticosteroids
Figure: Device market share for inhaled corticosteroids
Figure: Device market share for inhaled anticholinergics monotherapy
Figure: Device market share for inhaled anticholinergics + β2 stimulants
Figure: Device market share for long-acting β2 stimulants
Figure: Membrane permeation-controlled TDDS
Figure: Drug-in-adhesive TDDS
Figure: Matrix-dispersion-controlled TDDS
Figure: Microreservoir-dissolution-controlled TDDS
Figure: Global implantable formulation market by type of device, 2009
Figure: Geographical distribution of IUD users, 2009
Figure: Biophan’s nanomagnetic particle-based technology
Figure: Schematic diagram of the Synchromed implantable infusion pump

申込フォームお問合せ

株式会社 新社会システム総合研究所 東京都港区西新橋 2-6-2 友泉西新橋ビル 4F TEL 03-5532-8850